{"id":"NCT00693420","sponsor":"Allergan","briefTitle":"Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-04","primaryCompletion":"2007-10","completion":"2007-12","firstPosted":"2008-06-09","resultsPosted":"2009-05-12","lastUpdate":"2013-10-30"},"enrollment":278,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Eyelashes"],"interventions":[{"type":"DRUG","name":"Bimatoprost 0.03% sterile solution","otherNames":["LUMIGANÂ®"]},{"type":"DRUG","name":"vehicle sterile solution","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.","primaryOutcome":{"measure":"Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 16","timeFrame":"Baseline to Week 16","effectByArm":[{"arm":"Bimatoprost 0.03% Solution","deltaMin":5.1,"sd":null},{"arm":"Vehicle Solution","deltaMin":2.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":2,"countries":["United States","Canada"]},"refs":{"pmids":["23873891"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Upper respiratory tract infection","Eye pruritus","Pinguecula","Conjunctival hyperaemia","Eye Irritation"]}}